Neurohealth Limited 12246999 false 2023-11-01 2024-10-31 2024-10-31 The principal activity of the company is specialists medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 12246999 2023-11-01 2024-10-31 12246999 2024-10-31 12246999 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 12246999 bus:Micro-entities 2023-11-01 2024-10-31 12246999 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 12246999 bus:FilletedAccounts 2023-11-01 2024-10-31 12246999 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 12246999 bus:RegisteredOffice 2023-11-01 2024-10-31 12246999 bus:Director1 2023-11-01 2024-10-31 12246999 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 12246999 countries:England 2023-11-01 2024-10-31 12246999 2022-11-01 2023-10-31 12246999 2023-10-31 12246999 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 iso4217:GBP xbrli:pure

Registration number: 12246999

Neurohealth Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 October 2024

 

Neurohealth Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Neurohealth Limited

Company Information

Director

Dr Pablo Miguel Garcia Reitboeck

Registered office

7 Ulverscroft Road
London
SE22 9HF

Accountants

Carbon Accountancy Limited
Chartered Accountants
80-83 Long Lane
London
EC1A 9ET

 

Neurohealth Limited

(Registration number: 12246999)
Balance Sheet as at 31 October 2024

2024
£

2023
£

Fixed assets

2,630

1,924

Current assets

232,043

147,250

Creditors: Amounts falling due within one year

(48,418)

(32,669)

Net current assets

183,625

114,581

Total assets less current liabilities

186,255

116,505

Accruals and deferred income

(1,993)

(1,993)

 

184,262

114,512

Capital and reserves

184,262

114,512

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
7 Ulverscroft Road
London
SE22 9HF
England

These financial statements were authorised for issue by the director on 25 July 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

3

Related party transactions

The amount due from the director at the year end was £106,223, paid shortly after year end(£79,397 - 2023)
Interest has been charged on the due amount @2.5%

For the financial year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Neurohealth Limited

(Registration number: 12246999)
Balance Sheet as at 31 October 2024

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 25 July 2025
 

.........................................
Dr Pablo Miguel Garcia Reitboeck
Director